Brief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT

Hims & Hers Health

Wed 13:33

       Oct 21 (Reuters) - Hims & Hers Health, Inc.  HIMS.N :
    * HIMS EXPANDS TESTOSTERONE CARE WITH INJECTABLE AND ORAL
TRT
    * TESTOSTERONE OFFERING SCALING RAPIDLY AS OF Q2 2026
    * LAUNCHES TWICE-WEEKLY SUBCUTANEOUS INJECTION FOR
TESTOSTERONE INCREASE
    * PROVIDES THREE NEW TESTOSTERONE TREATMENT OPTIONS STARTING
TODAY
    * LAUNCHES WEEKLY INTRAMUSCULAR GENERIC TESTOSTERONE
CYPIONATE INJECTION
    * LAUNCHES FDA-APPROVED KYZATREX ORAL TRT FOR NORMAL
TESTOSTERONE IN 90 DAYS

    Source text:  ID:nBw9lW1x8a 
    Further company coverage:  HIMS.N 

 ((Reutersbriefs@thomsonreuters.com;))